“Ozempic penis” is an informal term describing changes men notice in their genitals after losing significant weight on semaglutide (sold as Ozempic or Wegovy) or similar GLP-1 medications. The term covers two distinct experiences that often get lumped together: the penis appearing larger as fat in the pubic area shrinks, and, less commonly, erectile difficulties or changes in sexual function that develop during treatment.
Why the Penis Looks Different After Weight Loss
There is no scientific evidence that GLP-1 medications cause actual penile tissue growth, and no known biological mechanism would make that possible. What happens is simpler: when men carry excess weight, a thick pad of fat in the lower abdomen and pubic region buries the base of the penis. As that fat disappears, more of the shaft becomes visible. The penis itself hasn’t changed size, but it can look noticeably longer.
This effect isn’t unique to Ozempic. It happens with any form of significant weight loss, whether from bariatric surgery, diet, or exercise. GLP-1 medications just produce dramatic weight loss quickly enough that the change catches people off guard. Some men also notice changes in skin laxity around the area, which can temporarily alter the appearance further. Loose skin generally takes at least six months at a stable weight before it finishes retracting on its own.
The Erectile Dysfunction Question
The more medically relevant side of “Ozempic penis” involves erectile function. A database study of over 3,000 non-diabetic, obese men ages 18 to 50 found that those prescribed semaglutide were 4.5 times more likely to be diagnosed with erectile dysfunction or prescribed ED medication compared to a matched group of obese men not taking the drug (1.47% vs. 0.32%). The same study found semaglutide users were about twice as likely to be diagnosed with low testosterone (1.53% vs. 0.80%).
Those relative risk numbers sound alarming, but the absolute numbers tell a more reassuring story. Fewer than 2 out of every 100 men on semaglutide in the study developed these issues. An analysis of the FDA’s adverse event reporting system, covering reports from 2003 through early 2024, identified just 182 total cases of male sexual dysfunction across all GLP-1 medications combined. The statistical measures in that analysis suggested a weak overall association between the drug class and sexual side effects.
So the risk appears real but small, and researchers still can’t say definitively whether semaglutide itself causes erectile problems or whether other factors, like rapid hormonal shifts during weight loss, are responsible.
How Weight Loss Affects Testosterone and Erections
The relationship between GLP-1 drugs and sexual function is genuinely complicated because weight loss itself changes hormone levels in ways that usually help. A meta-analysis pooling data from over 200 patients found that GLP-1 treatment significantly increased both total testosterone and bioavailable testosterone. The likely explanation is straightforward: excess body fat converts testosterone into estrogen and suppresses the hormonal signals that maintain healthy testosterone levels. Losing fat reverses that process.
A landmark trial published in JAMA found that roughly one-third of obese men with erectile dysfunction regained normal sexual function through weight loss and increased exercise alone. The improvement was tied to better blood vessel function and reduced inflammation, both of which directly affect the ability to get and maintain erections. Nitric oxide, the molecule that relaxes blood vessels in the penis to allow an erection, becomes more available as vascular health improves.
Lab studies on related GLP-1 drugs suggest they may even have direct benefits on penile tissue. One drug in the class has been shown to promote tissue remodeling in the penis independently of its weight loss effects, and another appears to support the smooth muscle relaxation needed for erections by reducing oxidative stress. These findings come from animal and cell studies, though, not from clinical trials in men.
Why Some Men Still Develop Problems
If weight loss generally improves sexual function, why do some men on semaglutide experience the opposite? Several factors may contribute. Rapid weight loss can cause temporary hormonal disruption as the body adjusts. Men on these medications often eat significantly less, which can lead to nutritional deficiencies that affect energy and libido. The gastrointestinal side effects, including nausea and reduced appetite, can dampen interest in sex independently of any hormonal change.
There’s also a detection bias worth noting. Men who start a new medication are seeing their doctors more frequently, which means problems like mild ED that might have gone unmentioned are more likely to get diagnosed and documented. Many men taking semaglutide also have diabetes or prediabetes, conditions that independently carry a high risk of erectile dysfunction from nerve and blood vessel damage.
What You Can Do About It
If you’ve noticed your penis looks different after weight loss on a GLP-1 medication, that’s almost certainly the expected result of losing fat in the pubic area. No treatment is needed, and it’s generally considered a cosmetic benefit of the weight loss.
If you’re experiencing erectile difficulties or a noticeable drop in libido, those are worth bringing up with a doctor, ideally a urologist who specializes in sexual medicine. Effective treatments for ED range from oral medications to more advanced options like low-intensity shockwave therapy or penile injections. In many cases, the issue may resolve on its own as your weight stabilizes and your hormones recalibrate. The general recommendation for any body changes related to rapid weight loss is to allow at least six months at a stable weight before evaluating what’s permanent and what’s still adjusting.
Staying physically active during weight loss appears to be protective. The research consistently links exercise to improved blood vessel function and better erectile outcomes, effects that go beyond what weight loss alone provides.